Company news
Healios Kk (TSE:4593) news
Healios Kk news releases on 6ix. Latest, Sep 30, 2026: Notice Regarding Shipment Timing of Initial Order of Culture Supernatant Products to JENECELL
Press releases & updates
Notice Regarding Shipment Timing of Initial Order of Culture Supernatant Products to JENECELL
September 30, 2026
FY2026 Q2 Financial Results (Material)
August 12, 2026
Healios Selected for the AMED “Project to Promote the Industrialization of Regenerative/Cell Medicine and Gene Therapy”
July 26, 2026
Notice Regarding the Filing of a Counterclaim in Response to a Lawsuit Filed Against Healios
June 9, 2026
Healios K.K. to Present at Jefferies Global Healthcare Conference
November 11, 2025
Healios K.K. to Present at Chardan’s 9th Annual Genetic Medicines Conference
October 20, 2025
Healios K.K. to Present at the 2025 Jefferies Global Healthcare Conference
May 28, 2025
Healios K K : TREASURE study results to be presented at the 14th World Stroke Congress
August 10, 2022
Healios K K : Exercise of Exclusive Option for a License Agreement with STEMAXON for the Development of UDC-Derived Photoreceptor Cells
July 12, 2022
Healios eNK Cells: Regenerative Medicine Product Quality Consultation with the PMDA for Planned Clinical Trials
July 12, 2022
Healios K K : Business Briefing for Institutional Investors
April 5, 2022
Healios K K : Progress Update in Relation to Application for Approval for HLCM051 for ARDS
April 4, 2022
Healios K K : Completion of 365 Days Post-Administration Follow Up for TREASURE Study for Patients with Ischemic Stroke
April 4, 2022
Healios K K : Joint Research with the Division of Regenerative Medicine, the Institute of Medical Science for Developing a Mass Production Method of UDC Liver Buds
April 1, 2022
Healios K K : License Agreement with CellFiber Co., Ltd.
March 24, 2022
Healios K K : Notice of the Partial Amendments to Articles of Incorporation
February 24, 2022
Healios K K : Notice of the Nomination of Candidates for the HEALIOS K.K. Board of Directors
February 24, 2022
Healios K K : Notice Concerning Reduction of Capital Stock and Capital Reserves and Appropriation of Surplus
February 24, 2022
Healios K K : Announcement of Change in Management
January 31, 2022
Healios K K : ’ Gene-Edited NK Cells：Joint Research with Hiroshima University for Hepatocellular Carcinoma
December 20, 2021
FY2021 Q3 Financial Results
November 12, 2021
Healios K K : Announcement of Determination of the Issue Price and Other Matters for the Issuance of New Shares through an International Offering
September 15, 2021
Healios K K : Announcement of Issuance of New Shares through an International Offering
September 15, 2021
Healios K K : Successful differentiation of Healios UDCs into pancreatic β-cells in our joint research with the National Center for Global Health and Medicine
September 2, 2021
Healios K K : Full Enrolment of TREASURE Study for Patients with Ischemic Stroke
August 10, 2021